NVHR wishes you a very happy and healthy holiday season. 2016 has been a very exciting and productive year in the fight against hepatitis B and C. Together, we have won many important victories that will increase access to hepatitis B and C testing, care, and treatment. We have much more work to be done in 2017 not only to move closer to our goal of eliminating hepatitis in the United States, but to save and protect the safety net health care system that serves so many communities impacted by hepatitis B and C. We thank you for all you do to fight viral hepatitis and look forward to our continued work together next year.
NVHR/CHLPI Report on Medicaid Access
On November 14, 2016, NVHR and the Center for Health Law and Policy Innovation of Harvard Law School released Hepatitis C: The State of Medicaid Access. This preliminary report shows some improvement in state Medicaid transparency and hepatitis C treatment access since 2014, yet demonstrates that most states continue to have discriminatory restrictions. NVHR and CHLPI will release a final report, along with state report cards, in early 2017.
NVHR Employment Opportunity
NVHR is seeking a full-time Program Coordinator to support and help expand our programmatic activities. For a complete job description, including required qualifications, salary and benefits, and how to apply, please review the job posting here.
NVHR Program Mini-Grants
NVHR is excited to announce that we will continue our mini-grants opportunity in 2017! Mini-grants will be made available to several NVHR member organizations. These grants will support hepatitis C education, screening, and/or linkage to care activities. We will release a request for proposals with more details in early 2017.
NVHR thanks our funders for their generous support in 2016: Centers for Disease Control and Prevention, Gilead Sciences, Gilead Foundation, AbbVie, Merck, Janssen, Bristol-Myers Squibb, Quest Diagnostics, Walgreens, and OraSure Technologies.